159 related articles for article (PubMed ID: 35763110)
41. SNHG3/miR-2682-5p/HOXB8 promotes cell proliferation and migration in oral squamous cell carcinoma.
Lu N; Yin Y; Yao Y; Zhang P
Oral Dis; 2021 Jul; 27(5):1161-1170. PubMed ID: 32989886
[TBL] [Abstract][Full Text] [Related]
42. GATA6‑induced FN1 activation promotes the proliferation, invasion and migration of oral squamous cell carcinoma cells.
Zhai J; Luo G
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35088888
[TBL] [Abstract][Full Text] [Related]
43. IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma.
Hu Y; Chen J; Liu M; Feng Q; Peng H
Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36281789
[TBL] [Abstract][Full Text] [Related]
44. Downregulated microRNA-149-3p triggers malignant development and predicts worse prognosis in oral squamous cell carcinoma.
Shen Q; Xiong P; Yang D; Chen L
Arch Oral Biol; 2022 Feb; 134():105336. PubMed ID: 34891100
[TBL] [Abstract][Full Text] [Related]
45. miR-340-5p affects oral squamous cell carcinoma (OSCC) cells proliferation and invasion by targeting endoplasmic reticulum stress proteins.
Ou D; Wu Y; Zhang J; Liu J; Liu Z; Shao M; Guo X; Cui S
Eur J Pharmacol; 2022 Apr; 920():174820. PubMed ID: 35227681
[TBL] [Abstract][Full Text] [Related]
46. Long non-coding RNA LINC01137 contributes to oral squamous cell carcinoma development and is negatively regulated by miR-22-3p.
Du Y; Yang H; Li Y; Guo W; Zhang Y; Shen H; Xing L; Li Y; Wu W; Zhang X
Cell Oncol (Dordr); 2021 Jun; 44(3):595-609. PubMed ID: 33797737
[TBL] [Abstract][Full Text] [Related]
47. Construction and clinical evaluation of N6-methyladenosine risk signature of YTHDC2, IGF2BP2, and HNRNPC in head and neck squamous cell carcinoma.
Yue Q; Xu L; Zhang D
Hua Xi Kou Qiang Yi Xue Za Zhi; 2022 Dec; 40(6):704-709. PubMed ID: 36416324
[TBL] [Abstract][Full Text] [Related]
48. Circ_0058063 contributes to oral squamous cell carcinoma development by sponging miR-145-5p and upregulating SERPINE1.
Yu J; Lou Y; Hou M; Ma X; Wang L
J Oral Pathol Med; 2022 Aug; 51(7):630-637. PubMed ID: 35778962
[TBL] [Abstract][Full Text] [Related]
49. Long non‑coding RNA AFAP1‑AS1 facilitates the growth and invasiveness of oral squamous cell carcinoma by regulating the miR‑145/HOXA1 axis.
Li M; Yu D; Li Z; Zhao C; Su C; Ning J
Oncol Rep; 2021 Mar; 45(3):1094-1104. PubMed ID: 33650645
[TBL] [Abstract][Full Text] [Related]
50. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
[TBL] [Abstract][Full Text] [Related]
51. Study on the expression and function of chordin-like 1 in oral squamous cell carcinoma.
Han Y; Xia L; Wang X; Xiong H; Zeng L; Wang Z; Zhang T; Xia K; Hu X; Su T
Oral Dis; 2023 Jul; 29(5):2034-2051. PubMed ID: 35510812
[TBL] [Abstract][Full Text] [Related]
52. NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation.
Zhang G; Zhao X; Liu W
Cancer Biol Ther; 2022 Dec; 23(1):243-253. PubMed ID: 35316145
[TBL] [Abstract][Full Text] [Related]
53. MARCH1 silencing suppresses growth of oral squamous cell carcinoma through regulation of PHLPP2.
Liu L; Guo B; Han Y; Xu S; Liu S
Clin Transl Oncol; 2022 Jul; 24(7):1311-1321. PubMed ID: 35122633
[TBL] [Abstract][Full Text] [Related]
54. MiR-4282 inhibits tumor progression through down-regulation of ZBTB2 by targeting LIN28B in oral squamous cell carcinoma.
Zhang Y; Zhang Z; Huang W; Zeng J
J Cell Physiol; 2020 Nov; 235(11):8035-8047. PubMed ID: 31970774
[TBL] [Abstract][Full Text] [Related]
55. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
56. Sodium butyrate inhibits oral squamous cell carcinoma proliferation and invasion by regulating the HDAC1/HSPB7 axis.
Yue HQ; Xu PF; Guo YD; Qi J; Liu RM; Li DH
Neoplasma; 2022 Sep; 69(5):1029-1040. PubMed ID: 35652621
[TBL] [Abstract][Full Text] [Related]
57. [Effect and mechanism of circular RNA BICD2 on the biological behavior of oral squamous cell carcinoma cells].
Zhang YJ; Zhu QQ; Zhou HX; Wang HY; Zhou H
Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Nov; 56(11):1098-1108. PubMed ID: 34763405
[No Abstract] [Full Text] [Related]
58. LINC00662 Promotes Oral Squamous Cell Carcinoma Cell Growth and Metastasis through miR-144-3p/EZH2 Axis.
Yao Y; Liu Y; Jin F; Meng Z
Yonsei Med J; 2021 Jul; 62(7):640-649. PubMed ID: 34164962
[TBL] [Abstract][Full Text] [Related]
59. A micro-peptide encoded by HOXB-AS3 promotes the proliferation and viability of oral squamous cell carcinoma cell lines by directly binding with IGF2BP2 to stabilize c-Myc.
Leng F; Miu YY; Zhang Y; Luo H; Lu XL; Cheng H; Zheng ZG
Oncol Lett; 2021 Oct; 22(4):697. PubMed ID: 34457052
[TBL] [Abstract][Full Text] [Related]
60. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR.
Dong L; Geng Z; Liu Z; Tao M; Pan M; Lu X
Pathol Res Pract; 2021 Sep; 225():153550. PubMed ID: 34340128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
